Nemonoxacin Completed Phase 3 Trials for Bacterial Pneumonia Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03551210An International, Multicenter, Randomized, Double-blind, Double-dummy, Two-way, Parallel Group, Controlled Study to Compare the Efficacy and Safety of Intravenous and Oral Nemonoxacin Versus TavanicĀ® in Adult Patients With Community-acquired Pneumonia